Intercept Pharmaceuticals
In David Einhorn's portfolio · Greenlight Capital
Ticker ICPT
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2021 | Sell | 0 | |
| Q4 2020 | Reduce 18% | 81,856 | 0.1% |
| Q3 2020 | Buy | 100,000 | 0.3% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.